3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
5
Terminated
3
Completed
3
Withdrawn
1
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Peritoneal Neoplasms
1
Peritoneal Diseases
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Fallopian Tube Neoplasms
1
Colorectal Neoplasms
1
Carcinoma, Ovarian Epithelial
1
Appendiceal Neoplasms
1
Interventions
Carboplatin
5
niraparib
2
Taxes
2
Paclitaxel
2
Gemcitabine
2
Cyclophosphamide
2
Bevacizumab
2
talazoparib
1
sargramostim
1
palbociclib
1
oregovomab
1
olaparib
1
epacadostat
1
dostarlimab
1
birinapant
1
atezolizumab
1
aldesleukin
1
Specimen Handling
1
Sirolimus
1
Selenium
1
Polymerase Chain Reaction
1
N-(5-(2,3-dihydrobenzofuryl)sulfonyl)-N'-(3,4-dichlorophenyl)urea
1
Metformin
1
Magnetic Resonance Spectroscopy
1
Letrozole
1
Injections
1
Hyperthermic Intraperitoneal Chemotherapy
1
Gene Expression Profiling
1
Fulvestrant
1
Colony-Stimulating Factors
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Fallopian Tube Neoplasms
×
Hyperthermic Intraperitoneal Chemotherapy
×
Clear all
NCT02487849
2020-03-04
HIPEC
Krankenhaus Barmherzige Schwestern Linz
Phase 2
Withdrawn